Results 171 to 180 of about 602,046 (339)

End-of-Life Care Decisions: Importance of Reviewing Systems and Limitations After 2 Recent North American Cases [PDF]

, 2012
Christopher M. Burkle, Jeffre J. Benson
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Self-reported anal cancer screening experiences in MSM: recency, follow-up, and methodological insights. [PDF]

Front Oncol
Bennis SL, Smith MK, Luo X, Baker JV, Enns EA, Kulasingam S.   +5 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Developing and evaluating a novel rapid test for recent HIV-1 infection: comparison with commercial LAg-EIA assays. [PDF]

J Clin Microbiol
Liu J, Liu P, Ye R, Yao S, Zhu Q, Jiang Y, Jin C.   +6 more
europepmc   +1 more source

Recent trends in the rate of trabeculectomy in England [PDF]

, 2011
Tiarnán D L Keenan, Clare J. Wotton, Michael J Goldacre   +2 more
openalex   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Reward-based prioritization in working memory is distinct from recency and due to a resource trade-off. [PDF]

Psychon Bull Rev
Ricker TJ, Cagna CJ, Tong TT, Dobryakova E, Sandry J.   +4 more
europepmc   +1 more source

Review of: Recent trends in climate variability at the local scale using 40 years of observations: the case of the Paris region France.

, 2019
Robert Davies-Jones ; Diffenbaugh, Jeremy Pal, Filippo Giorgi, Xuejie Gao, E M, K Fischer, D M W Oleson, Lawrence, Carlos, D Hoyos, Peter Webster, L S Kalkstein, J S Greene, Robert L Korty, Kerry Emanuel, Matthew Huber, Ryan Zamora, Rahul Kumar, Vimal Mishra, Jonathan Buzan, Rohini Kumar, Drew Shindell, Matthew Huber, Lawrence Mark, K R Tom, Robert Matthews, Conor Wilby, Murphy, Brigitte Mueller, Sonia Seneviratne, ; C Sherwood, Matthew Huber, ; Katharine, M Willett, Steven Sherwood, Ian, Raymond Williams, Matthew Pierrehumbert, Huber, N Ian, Raymond Williams, Pierrehumbert, Ryan Zamora, Robert Korty, Matthew Huber   +44 more
openalex   +1 more source

Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma

Molecular Oncology, EarlyView.
This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns, Jaclyn S. Long, Sergio Lilla, Kelly Hodge, Marcus J. G. W. Ladds, Colin Nixon, Paula Fernández‐Palanca, Sara Zanivan, Pilar Acedo, Stephen P. Pereira, Kevin M. Ryan   +10 more
wiley   +1 more source